Source: Annual Congress 2002 - Malignant and benign intrathoracic tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
F. J. Montoro Zulueta, V. Villena, R. Garcia Lujan, M. I. Verdugo, A. Lopez Encuentra, P. Martin Escribano, B. Ortuno de Solo, J. Estenoz Alfaro (Madrid, Spain). Diagnostic value of CEA, CA 549, CA 15.3 , CA 72.4 in pleural fluid and comparison with cytology. Eur Respir J 2002; 20: Suppl. 38, 2788

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of pleural fluid levels and pleural-serum ratio of the tumor markers CEA, CA 15,3, CA 19,9, CA 72,4, CA 125 and CYFRA 21,1 in the diagnosis of malignant pleural effusion Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003 Diagnostic value of CYFRA 21-1, CEA, CA19-9, CA 15-3, and CA 125 assay in pleural effusions: analysis of 116 cases and review of the literature Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005 Diagnostic value of a third pleural biopsy Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 The diagnostic value of the examination of the tumor markers CYFRA 21-1, NSE, TPA and CEA from the bronchoalveolar lavage fluid in diffuse pulmonary disorders Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Clinical evaluation of NSE, CYFRA 21-1, CEA and MCA at patients (pts.) with metastatic pleural effusion (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 Diagnostic value of linear combination of CYFRA 21-1 and carcinoembryonic antigen in malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 The value of cytology in pleural effusions vs histology by medical thoracoscopy Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Negative predictive value of pleural fluid cytology in patients with a background of cancer. Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Comparative evaluation of CA-125, CA 19-9, CA 15-3 and CEA in exudative benign and malignant pleural effusion Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 The value of mesothelin in pleural effusion vs histology by medical thoracoscopy Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 The diagnostic value of CA-125 in pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001 Diagnostic comparison between pleural fluid cytology (PFC), cellular block (CB) and pleural biopsy (PB) under visual guidance Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Diagnostic utility of CYFRA 21-1 and carcinoembryonic antigen as a tumour markers in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 CEA, Cyfra 21.1 and NSE levels in malignant and benign pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002 Diagnostic value of pleural needle biopsy Source: Eur Respir J 2004; 24: Suppl. 48, 249s Year: 2004 Diagnostic value of amylase levels in pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 The diagnostic value of the total adenosine deaminase(ADAp) and ADA1/ADAp ratio in the diagnosis of tuberculous pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 168s Year: 2002 Medical thoracoscopy- Comparison of pleural biopsy, imprint cytology and cytology of pleural effusion Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions Year: 2019